Nature Communications

Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial

2026-04-23

Full text

DOI https://doi.org/10.1038/s41467-026-72059-7